Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauri E Markowitz

Showing results (111-120 of 290) with videos related to

Pageof 29
Sort By:
Vaccine|January 16, 2021
Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose scheduleHilary S Whitworth, John Schiller, Lauri E Markowitz, et al.
The Journal of Infectious Diseases|July 28, 2011
Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States--National Health And Nutrition Examination Survey, 2003-2006: opportunity to measure HPV vaccine impact?Eileen F Dunne, Maya Sternberg, Lauri E Markowitz, et al.
The Journal of Infectious Diseases|July 28, 2011
Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006Susan Hariri, Elizabeth R Unger, Maya Sternberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 23, 2021
Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United StatesElissa Meites, Laura Stone, Raiza Amiling, et al.
MMWR. Morbidity and Mortality Weekly Report|August 16, 2019
Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization PracticesElissa Meites, Peter G Szilagyi, Harrell W Chesson, et al.
The Journal of Infectious Diseases|April 24, 2004
Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of ageStephen C Redd, Gail E King, Janet L Heath, et al.
The Journal of Infectious Diseases|June 21, 2013
Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010Lauri E Markowitz, Susan Hariri, Carol Lin, et al.
Journal of Clinical Microbiology|February 6, 2009
Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infectionsLaura H Bachmann, Robert E Johnson, Hong Cheng, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|September 28, 2016
Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry DataPreeti Pathela, Kelly Jamison, Vikki Papadouka, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|September 14, 2019
Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National SurveyNancy M McClung, Rayleen M Lewis, Julia W Gargano, et al.
Pageof 29

Showing results (111-120 of 290) with videos related to

Sort By:
Pageof 29
Vaccine|January 16, 2021
Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose scheduleHilary S Whitworth, John Schiller, Lauri E Markowitz, et al.
The Journal of Infectious Diseases|July 28, 2011
Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States--National Health And Nutrition Examination Survey, 2003-2006: opportunity to measure HPV vaccine impact?Eileen F Dunne, Maya Sternberg, Lauri E Markowitz, et al.
The Journal of Infectious Diseases|July 28, 2011
Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006Susan Hariri, Elizabeth R Unger, Maya Sternberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 23, 2021
Significant Declines in Juvenile-onset Recurrent Respiratory Papillomatosis Following Human Papillomavirus (HPV) Vaccine Introduction in the United StatesElissa Meites, Laura Stone, Raiza Amiling, et al.
MMWR. Morbidity and Mortality Weekly Report|August 16, 2019
Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization PracticesElissa Meites, Peter G Szilagyi, Harrell W Chesson, et al.
The Journal of Infectious Diseases|April 24, 2004
Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of ageStephen C Redd, Gail E King, Janet L Heath, et al.
The Journal of Infectious Diseases|June 21, 2013
Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010Lauri E Markowitz, Susan Hariri, Carol Lin, et al.
Journal of Clinical Microbiology|February 6, 2009
Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infectionsLaura H Bachmann, Robert E Johnson, Hong Cheng, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|September 28, 2016
Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry DataPreeti Pathela, Kelly Jamison, Vikki Papadouka, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|September 14, 2019
Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National SurveyNancy M McClung, Rayleen M Lewis, Julia W Gargano, et al.
Pageof 29